Free Trial

HEALTHCARE: Bayer (BAYNGR: Baa2 neg / BBB / BBB): Trial Win

HEALTHCARE
  • Positive: On Sep 3rd, Bayer won another case - this time in Missouri
  • This wasn't reported on Bloomberg, in the Monsanto v Moore case the Appeals court supported Bayer in barring testimony from an expert witness for the litigant.
  • The No1 strategy for Bayer is to have the US Supreme Court pre-empt state law by stating that the Environmental Protection Agency's designation of RoundUp as being safe supersedes any need to warn users.
  • The Young v Monsanto case in Philadelphia will be watched closely as it could be the 5th victory for Bayer that court. Verdict expected mid-Sept.
  • The appointment of Bill Anderson (a Texan) reminds me of BP's decision to appoint Bob Dudley after the Deepwater Horizon accident.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.